Cupertino, CA (PRWEB) May 27, 2005
M7 Corporation, Inc., the leader in web application development tools based on open source and open standard technologies, today introduced NitroX JSF IDE. NitroX was created to be the most comprehensive tool to meet the needs of professional JavaÂ developers building web applications based on open standards such as JSF, Struts and JSP. As open source and open standard technologies have continued to thrive, M7 has continued to deliver professional tools to support the development for these open standards. NitroX JSF IDE provides the following key benefits:
Synchronized and Simultaneous Source and Visual JSF Development
NitroX extends its critically acclaimed visual editor to support WYSIWYG development with JSF components within JavaServer Pages. JSF components can be visualized at design time with support for drag/drop of JSF CORE and JSF HTML tag libraries and includes context sensitive wizards that assist in the creation of new artifacts.
Intelligent Context Sensitive JSF Source Editor
NitroX AppXRayÂ extends the intelligent level of code completion and error checking efficiency to JSF development within the source editor. Code completion, error checking and validation of JSF components are readily available including intelligence of variables and methods of related managed beans. Hyperlink-style navigation (AppXnavigatorÂ) is expanded to support the JSF framework thereby making navigation through the various elements, a trivial task.
JavaServer Faces Configuration
NitroX offers a Navigation and Forms editor views for the faces-config.xml configuration file. Both editors benefit from the depth of intelligence that AppXRay provides and the unique ability of simultaneously synchronized, 2-way, source and visual editing.
Reaction from Developers
ÂI have been looking at IDE's that support JSF technology for some time. M7's NitroX for JSF provides both drag-and-drop capabilities as well as maintaining a strong ability to work with the underlying code easily. NitroX for JSF is by far the easiest IDE I've used for JSF development. Its JSP editor with split code/screen capabilities actually make developing JSP/JSF pages enjoyable. The debugging of your application from the JSP page itself down into the guts of the code makes problem resolution much easier.Â
- Lee M Seidel, Manager, EC/Web Enterprises, Capital BlueCross
"Web development these days requires knowledge of a plethora of different artifacts. Unfortunately, most tools don't understand how those artifacts are related. M7's NitroX for JSF has a keen understanding of your project, and it lets you know when something is out of synch. Add in a nice WYSIWYG editor, two-way tools, and Eclipse support, and you've got a winning package. Once you begin working with a tool this smart, it's hard to go back."
Kito D. Mann, editor-in-chief, JSF Central
Pricing and Availability
NitroX JSF IDE is priced at $499. A new purchase includes a one-year subscription for product updates, bug fixes and includes major version upgrades of the product that become available during the term of the subscription. No version games, just pure productivity. To purchase, please visit: http://www.m7.com or contact M7 Sales at email@example.com (1.866.770.9770).
About M7 Corporation
M7 Corporation, Inc, the leader in web application tools based on open source and open standard technologies, is exclusively focused on improving the development of web applications for serious developers who want to avoid platform lock-in. M7 draws on its long history of experience in understanding the complexity of web application development Â the proliferation of J2EE platforms, web containers, web application frameworks such as Struts and public and custom tag libraries. Drawing on this depth of understanding, M7 develops innovative products, such as NitroX, which fuel an incredibly high level of productivity in creating, editing, or debugging any part of a complex web application.
Based in Cupertino, CA, M7 is privately held and venture backed by Highland Capital Partners, Redpoint Ventures, CIR Ventures and Genevest. For additional information, visit the companyÂs web site at http://www.m7.com
# # #